Market Research Logo

Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review

Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imaging products comprising contrast media for X-Ray imaging and magnetic resonance imaging (MRI); delivery systems and services; and interventional imaging products. Guerbet has presence in Europe, Asia, Oceania and North and South America. The company offers products directly through its sales structure, distributors and license-holders. Guerbet is headquartered in Villepinte, France.

Guerbet SA Key Recent Developments

Jul 26,2018: GUERBET : Revenue at June 30 2018
Jul 10,2018: IBM Watson Health and Guerbet to use AI in medical imaging
Jul 09,2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division
Apr 18,2018: Guerbet reports 1st quarter 2018 revenue
Apr 18,2018: GEAR 2023 strategic plan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Guerbet SA - Key Facts
Guerbet SA - Key Employees
Guerbet SA - Key Employee Biographies
Guerbet SA - Major Products and Services
Guerbet SA - History
Guerbet SA - Company Statement
Guerbet SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Guerbet SA - Business Description
Business Segment: Diagnostic Imaging
Overview
Performance
Key Stats
Business Segment: Interventional Imaging
Overview
Performance
Business Segment: Others
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Markets
Performance
R&D Overview
Guerbet SA - Corporate Strategy
Guerbet SA - SWOT Analysis
SWOT Analysis - Overview
Guerbet SA - Strengths
Guerbet SA - Weaknesses
Guerbet SA - Opportunities
Guerbet SA - Threats
Guerbet SA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Guerbet SA, Medical Equipment, Deals By Type, 2012 to YTD 2018
Guerbet SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 26, 2018: GUERBET : Revenue at June 30 2018
Jul 10, 2018: IBM Watson Health and Guerbet to use AI in medical imaging
Jul 09, 2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division
Apr 18, 2018: Guerbet reports 1st quarter 2018 revenue
Apr 18, 2018: GEAR 2023 strategic plan
Mar 27, 2018: Guerbet: 2017 Annual Results - Satisfactory activity slightly exceeding the objectives
Feb 19, 2018: David Hale Appoints Guerbet Executive Committee as Chief Commercial Officer, Diagnostic Imaging
Feb 15, 2018: GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7%
Dec 06, 2017: Gadolinium-based contrast agents: update on MHLW decision in Japan
Oct 25, 2017: GUERBET: Revenue at September 30, 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tabless
Guerbet SA, Key Facts
Guerbet SA, Key Employees
Guerbet SA, Key Employee Biographies
Guerbet SA, Major Products and Services
Guerbet SA, History
Guerbet SA, Other Locations
Guerbet SA, Subsidiaries
Guerbet SA, Key Competitors
Guerbet SA, Ratios based on current share price
Guerbet SA, Annual Ratios
Guerbet SA, Annual Ratios (Cont...1)
Guerbet SA, Annual Ratios (Cont...2)
Guerbet SA, Interim Ratios
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Guerbet SA, Medical Equipment, Deals By Type, 2012 to YTD 2018
Guerbet SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Guerbet SA, Performance Chart (2013 - 2017)
Guerbet SA, Ratio Charts
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018
Guerbet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report